2012The Chinese Journal of Clinical PharmacologyRequires access

Bioequivalence of ritodrine hydrochloride tablets in Chinese healthy volunteers

Heyao Wang

Open publisher page 0 citations

Abstract

Objective To evaluate the bioequivalence of two preparations of ritodrine hydrochloride tablets.Methods A single oral dose of 10 mg test and reference ritodrine hydrochloride tablets were given to 22 female healthy volunteers in a randomized crossover study.The concentrations of ritodrine hydrochloride were determined by HPLC-MS /MS method.The pharmacokinetic paramters and relative bioavailability were calculated by DAS 2.0 software,then the bioequivalence was judged.Results The main pharmacokinetic parameters of two preparations were as follows: Cmax were(5.71±1.83),(5.61±2.03) ng·mL-1,Tmax were(0.54±0.45),(0.46±0.24) h,t1/2 were(3.64±3.99),(4.25±4.02) h,AUC0-t were(12.31±5.20),(12.01±5.42) h·ng·mL-1,respectively.The relative bioavailability of test tablets was(105.3±19.96)%.The 90% CIs for the ratios of AUC0-t,Cmax were 95.8%-111.6%,95.4%-108.2%,respectively.Conclusion The results demonstrated that the two preparations were bioequivalent.

About this research paper

What this paper is about

Objective To evaluate the bioequivalence of two preparations of ritodrine hydrochloride tablets.Methods A single oral dose of 10 mg test and reference ritodrine hydrochloride tablets were given to 22 female healthy volunteers in a randomized crossover study.The concentrations of ritodrine hydrochloride were determined by HPLC-MS /MS method.The pharmacokinetic paramters and relative bioavailability were calculated by DAS 2.0 software,then the bioequivalence was judged.Results The main pharmacokinetic parameters of two preparations were as follows: Cmax were(5.71±1.83),(5.61±2.03) ng·mL-1,Tmax were(0.54±0.45),(0.46±0.24) h,t1/2 were(3.64±3.99),(4.25±4.02) h,AUC0-t were(12.31±5.20),(12.01±5.42) h·ng·mL-1,respectively.The relative bioavailability of test tablets was(105.3±19.96)%.The 90% CIs for the ratios of AUC0-t,Cmax were 95.8%-111.6%,95.4%-108.2%,respectively.Conclusion The results demonstrated that the two preparations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the bioequivalence of two preparations of ritodrine hydrochloride tablets.Methods A single oral dose of 10 mg test and reference ritodrine hydrochloride tablets were given to 22 female healthy volunteers in a randomized crossover study.The concentrations of ritodrine hydrochloride were determined by HPLC-MS /MS method.The pharmacokinetic paramters and relative bioavailability were calculated by DAS 2.0 software,then the bioequivalence was judged.Results The main pharmacokinetic parameters of two preparations were as follows: Cmax were(5.71±1.83),(5.61±2.03) ng·mL-1,Tmax were(0.54±0.45),(0.46±0.24) h,t1/2 were(3.64±3.99),(4.25±4.02) h,AUC0-t were(12.31±5.20),(12.01±5.42) h·ng·mL-1,respectively.The relative bioavailability of test tablets was(105.3±19.96)%.The 90% CIs for the ratios of AUC0-t,Cmax were 95.8%-111.6%,95.4%-108.2%,respectively.Conclusion The results demonstrated that the two preparations were bioequivalent.

Key concepts: Bioequivalence, Cmax, Bioavailability, Pharmacokinetics, Crossover study, Ritodrine, Hydrochloride, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of ritodrine hydrochloride tablets in Chinese healthy volunteers — Research Paper | ScholarLens